Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors as Add-On Therapy to Insulin Pumps for Type 1 Diabetes: A Systematic Review and Meta-Analysis | Synapse
March 3, 2026
Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors as Add-On Therapy to Insulin Pumps for Type 1 Diabetes: A Systematic Review and Meta-Analysis
Key Points
The efficacy of sodium-glucose cotransporter-2 inhibitors as add-on therapy improves glycemic control in type 1 diabetes patients.
Findings indicate a reduction in hemoglobin A1c by significant margins, optimizing diabetes management.
Systematic review and meta-analysis provide a comprehensive assessment of combined treatments for insulin-dependent diabetes.
This review highlights the need for more extensive trials, emphasizing the importance of safety assessments in long-term use.